Response to Biesecker et al
- PMID: 33420347
- DOI: 10.1038/s41436-020-01055-z
Response to Biesecker et al
Comment on
-
The role of clinical response to treatment in determining pathogenicity of genomic variants.Genet Med. 2021 Mar;23(3):581-585. doi: 10.1038/s41436-020-00996-9. Epub 2020 Oct 22. Genet Med. 2021. PMID: 33087887
-
Correspondence on "The role of clinical response to treatment in determining pathogenicity of genomic variants" by Shen et al.Genet Med. 2021 Mar;23(3):586. doi: 10.1038/s41436-020-01032-6. Epub 2020 Nov 6. Genet Med. 2021. PMID: 33154565 No abstract available.
References
-
- Biesecker, L. G., Harrison, S. M. & Rehm, H. L. Correspondence on “The role of clinical response to treatment in determining pathogenicity of genomic variants” by Shen et al. Genet. Med. https://doi.org/10.1038/s41436-020-01032-6 (2020).
-
- Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015). - DOI
-
- Shen, J. J. et al. The role of clinical response to treatment in determining pathogenicity of genomic variants. Genet. Med. https://doi.org/10.1038/s41436-020-00996-9 (2020).
-
- Kuroishi, T. Regulation of immunological and inflammatory functions by biotin. Can. J. Physiol. Pharmacol. 93, 1091–1096 (2015). - DOI
-
- Ortigoza-Escobar, J. D. et al. Thiamine deficiency in childhood with attention to genetic causes: survival and outcome predictors. Ann. Neurol. 82, 317–330 (2017). - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
